Up in Canada, students have developed an incredible new way to synthesize drugs on plants — and they're using semaglutide, ...
(RTTNews) - OPKO Health (OPK) and Entera Bio have entered a collaboration and license agreement to develop the first oral dual agonist GLP-1/glucagon peptide for obesity, metabolic, and fibrotic ...